Clinical evaluation of sodium amylosulfate in human blood cultures.
Sodium amylosulfate was shown to be a useful anticoagulant additive for increased isolation of bacteria from clinical blood cultures.
D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D000925:Anticoagulants; D001419:Bacteria / Q000302:isolation & purification*; D001431:Bacteriological Techniques; D001769:Blood; D003470:Culture Media; D046508:Culture Techniques; D003937:Diagnosis, Differential; D004926:Escherichia coli / Q000302:isolation & purification; D005069:Evaluation Studies as Topic; D006193:Haemophilus influenzae / Q000302:isolation & purification; D007709:Klebsiella / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000175:diagnosis*; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013431:Sulfates
D000925:Anticoagulants; D003470:Culture Media; D013431:Sulfates